|

FT819 Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Fate Therapeutics2

Indications

  • Lupus Nephritis2
  • Lupus2
  • Lupus Nephritis - WHO Class IV1
  • Lupus Nephritis - WHO Class III1
  • Idiopathic Inflammatory Myositis (IIM)1

Beverly Hills, California2 trials

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Wallace Rheumatic Center

Phase 1
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Wallace Rheumatic Studies Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.